‘The Swedish market is very competitive when it comes to biotech and pharma’
Ahmedabad-based Cadila Pharmaceuticals' tie up with NovaSAID of Sweden to develop innovative treatments in inflammation and pain…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Cadila Pharma ties up with NovaSAID
To develop innovative treatments in inflammation and pain management
Dr Reddy’s to launch hypertension drug Optidoz
Efficacy and safety of Optidoz has been established through the CONTROL-Hypertension clinical study
Ranbaxy and EPIRUS sign licensing agreement for biosimilar product
Ranbaxy to market in India and other emerging markets, after approval
Biocon launches CANMAb for breast cancer
CANMAb, developed jointly by Biocon and Mylan under a global partnership
Business Monitor releases report on India’s lifesciences sector
Report mentions that the government is impeding the development of its pharma sector, mainly due to extensive bureaucracy and poor…
Aurobindo’s European arm to acquire Actavis’ ops in 7 Euro nations
The acquisition will make Aurobindo one of the leading Indian pharmaceutical companies in Europe
Lilly India and Boehringer Ingelheim India launch re-usable insulin pen
HumaPen Savvio is designed to resemble a small personal accessory rather than a medical device to help manage diabetes discreetly
Gilead names Mylan as exclusive branded medicines business partner for India
Under the agreement, Mylan will market and distribute in India certain Gilead medications
IPM clocks Rs 6256 crores in December 2013
The IPM market grew for the second consecutive month, clocking a growth of 8.2 per cent